Who is the CEO of PLx Pharma Inc.?

Ms. Natasha Giordano is a business executive who currently serves as the CEO of PLx Pharma Inc..

What is the Revenue Growth of PLx Pharma Inc.?

Revenue growth data for PLx Pharma Inc. is currently unavailable.

What is PLx Pharma Inc. operating Margin?

PLx Pharma Inc. operating margin is -496.95% which shows how much profit PLXP earns from each dollar of sales, after subtracting the direct costs tied to generating that revenue.

In which market sector does PLx Pharma Inc. operate?

PLx Pharma Inc. falls under the Healthcare sector which thrives across multiple industries. It stays competitive through its diverse product lineup, which spans computer hardware, tech gadgets, video streaming services, and cloud computing solutions.

What is PLx Pharma Inc. revenue growth?

Revenue growth data for PLx Pharma Inc. is currently unavailable.

PLx Pharma Inc.

PLXP•NASDAQ

HealthcareDrug Manufacturers - Specialty & Generic

$0.09

$0.00(0.00%)

PLx Pharma Inc. (PLXP) Stock Overview

Explore PLx Pharma Inc.’s financial performance, market position, analyst ratings, and future outlook.

Stats data is not available for PLXPStats details for PLXP are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Analyst Recommendations data is not available for PLXPAnalyst Recommendations details for PLXP are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores, and e-commerce channels. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey.

CEO

Ms. Natasha Giordano

Employees

Headquarters

9 Fishers Lane, Sparta, NJ

Founded

2014